Cardiol Therapeutics Inc. (CRDL)
USD 0.97
(-0.52%)
USD 0.97
(-0.52%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -28.12 Million CAD | 9.06% |
| 2022 | -30.93 Million CAD | 2.24% |
| 2021 | -31.63 Million CAD | -53.28% |
| 2020 | -20.64 Million CAD | -50.84% |
| 2019 | -13.68 Million CAD | 13.9% |
| 2018 | -15.89 Million CAD | -856.92% |
| 2017 | -1.66 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -9.17 Million CAD | -20.2% |
| 2024 Q2 | -6.59 Million CAD | 28.2% |
| 2023 Q3 | -5.93 Million CAD | 20.63% |
| 2023 FY | -28.12 Million CAD | 9.06% |
| 2023 Q1 | -7.08 Million CAD | 5.66% |
| 2023 Q2 | -7.47 Million CAD | -5.39% |
| 2023 Q4 | -7.63 Million CAD | -28.78% |
| 2022 FY | -30.93 Million CAD | 2.24% |
| 2022 Q1 | -8.95 Million CAD | -43.09% |
| 2022 Q4 | -7.51 Million CAD | 5.73% |
| 2022 Q3 | -7.97 Million CAD | -22.85% |
| 2022 Q2 | -6.48 Million CAD | 27.52% |
| 2021 Q3 | -9.9 Million CAD | -51.05% |
| 2021 Q4 | -6.25 Million CAD | 36.86% |
| 2021 Q2 | -6.56 Million CAD | 26.36% |
| 2021 FY | -31.63 Million CAD | -53.28% |
| 2021 Q1 | -8.9 Million CAD | 7.83% |
| 2020 FY | -20.64 Million CAD | -50.84% |
| 2020 Q3 | -4.4 Million CAD | -21.43% |
| 2020 Q2 | -3.62 Million CAD | -22.92% |
| 2020 Q1 | -2.94 Million CAD | 3.6% |
| 2020 Q4 | -9.66 Million CAD | -119.63% |
| 2019 Q3 | -3.49 Million CAD | 4.14% |
| 2019 FY | -13.68 Million CAD | 13.9% |
| 2019 Q4 | -3.05 Million CAD | 12.4% |
| 2019 Q1 | -3.49 Million CAD | 61.53% |
| 2019 Q2 | -3.64 Million CAD | -4.35% |
| 2018 Q1 | -551.63 Thousand CAD | 6.23% |
| 2018 Q3 | -4.91 Million CAD | -261.5% |
| 2018 Q4 | -9.07 Million CAD | -84.79% |
| 2018 FY | -15.89 Million CAD | -856.92% |
| 2018 Q2 | -1.35 Million CAD | -146.23% |
| 2017 Q2 | -442.55 Thousand CAD | 0.0% |
| 2017 FY | -1.66 Million CAD | 0.0% |
| 2017 Q4 | -588.26 Thousand CAD | -9.8% |
| 2017 Q3 | -535.73 Thousand CAD | -21.05% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alvotech | -551.73 Million USD | 94.902% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 158.412% |
| Journey Medical Corporation | -3.85 Million USD | -630.036% |
| Dynavax Technologies Corporation | -6.38 Million USD | -340.261% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 79.861% |
| PainReform Ltd. | -9.34 Million USD | -201.031% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -524.235% |
| SCYNEXIS, Inc. | 67.04 Million USD | 141.957% |
| Silver Spike Investment Corp. | 7.34 Million USD | 483.214% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -524.235% |
| Bright Green Corporation | -13.12 Million USD | -114.268% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 86.557% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -257.412% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 249.786% |
| Alpha Teknova, Inc. | -36.78 Million USD | 23.523% |
| Embecta Corp. | 70.4 Million USD | 139.955% |
| Safety Shot Inc | -15.08 Million USD | -86.49% |
| Procaps Group, S.A. | 42.54 Million USD | 166.122% |
| Cosmos Health Inc. | -18.54 Million USD | -51.695% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -807.794% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 167.044% |
| Theratechnologies Inc. | -23.95 Million USD | -17.412% |
| Harrow Health, Inc. | -24.41 Million USD | -15.228% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -481.764% |
| Biofrontera Inc. | -20.13 Million USD | -39.726% |
| DURECT Corporation | -27.62 Million USD | -1.826% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 2237.408% |
| Cronos Group Inc. | -73.96 Million USD | 61.97% |
| OptiNose, Inc. | -35.48 Million USD | 20.727% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 97.193% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 33.344% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 217.613% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 668.823% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 17898.998% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -347.951% |
| Radius Health, Inc. | -25.79 Million USD | -9.062% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -356.401% |
| ProPhase Labs, Inc. | -16.78 Million USD | -67.61% |
| Phibro Animal Health Corporation | 2.41 Million USD | 1264.25% |
| Procaps Group S.A. | 42.54 Million USD | 166.122% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -173.675% |
| Viatris Inc. | 54.7 Million USD | 151.423% |
| Rockwell Medical, Inc. | -8.43 Million USD | -233.313% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -77.533% |
| SIGA Technologies, Inc. | 68.06 Million USD | 141.323% |
| Tilray Brands, Inc. | -244.98 Million USD | 88.518% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 334.149% |
| Shineco, Inc. | -22.44 Million USD | -25.299% |
| PetIQ, Inc. | 2.13 Million USD | 1419.957% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -553.867% |
| Incannex Healthcare Limited | -18.45 Million USD | -52.383% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 111.265% |
| Alimera Sciences, Inc. | -20.13 Million USD | -39.719% |
| Assertio Holdings, Inc. | -331.94 Million USD | 91.526% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -326.657% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -244.575% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | -57.15% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -40.24% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 82.45% |
| Hempacco Co., Inc. | -13.12 Million USD | -114.293% |
| Talphera, Inc. | -18.39 Million USD | -52.896% |
| Alvotech | -551.73 Million USD | 94.902% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 178.919% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 108.611% |
| Currenc Group, Inc. | -15.3 Million USD | -83.766% |
| Kamada Ltd. | 8.28 Million USD | 439.55% |
| Indivior PLC | 2 Million USD | 1506.415% |
| Evoke Pharma, Inc. | -7.79 Million USD | -260.976% |
| Flora Growth Corp. | -57.03 Million USD | 50.683% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -40.24% |
| Evolus, Inc. | -61.68 Million USD | 54.4% |
| HUTCHMED (China) Limited | 100.78 Million USD | 127.911% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 120.45% |
| Akanda Corp. | -32.27 Million USD | 12.848% |